Source: pio3 / Shutterstock.com
Revenue Growth through 2022: 2.1%
The first name on my list of the best long-term stocks is Pfizer, a company that has been in the news quite a bit lately.
However, Pfizer wasn’t always a high-potential company. After years of success in small-molecule drugs like Viagra and Zoloft, the firm managed to miss the biotech revolution completely. Today, four of the top five grossing drugs are biologics and Pfizer makes none of them.
Yet, things are starting to change behind the scenes for it and, in turn, PFE stock. Under its new CEO, Albert Bourla, the company has quietly grown its pipeline of biotech-related drugs. Plus, even Pfizer’s novel coronavirus vaccine made in partnership with a German biotech startup has demonstrated its willingness to try new routes.